IPC
SGMO

Independent Portfolio Consultants’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Independent Portfolio Consultants’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,930
Closed -$46K – 1013
2015
Q1 		$46K Sell
2,930
-80
-3% -$1.24K 0.01% 627
2014
Q4 		$46K Sell
3,010
-7,580
-72% -$92K 0.01% 637
2014
Q3 		$114K Buy
+10,590
New +$138K 0.03% 527

Other funds holding SGMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Independent Portfolio Consultants's SGMO Position: Q2 2015 in Review

Independent Portfolio Consultants sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2015, closing a stake of 2,930 shares — an estimated $46K sold.

Independent Portfolio Consultants first reported a position in SGMO in Q3 2014 and held it in 3 quarters. The position peaked at $114K in Q3 2014. 156 funds tracked by Wall St. Rank hold SGMO as of Q2 2015.

  • Independent Portfolio Consultants reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2015 after selling out during the quarter.
  • Independent Portfolio Consultants sold 2,930 SANGAMO THERAPEUTICS INC shares in Q2 2015, an estimated $46K.
  • Independent Portfolio Consultants first reported a position in SANGAMO THERAPEUTICS INC in Q3 2014 and held it in 3 quarters.
  • Independent Portfolio Consultants's SANGAMO THERAPEUTICS INC position peaked at $114K in Q3 2014.
  • 156 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2015.

Based on Independent Portfolio Consultants's 13F filing for Q2 2015, filed 27 Jul 2015.